
Health Enterprise Partners (HEP) is a private equity firm that focuses on growth equity and buy-and-build investments in lower middle-market healthcare information technology and services companies. Their strategy involves leveraging a network of strategic limited partners, including hospital systems and health plans, to invest in companies that improve patient outcomes, expand access, and reduce healthcare costs.
86% of their portfolio is in Healthcare. Their most common stage is series-a (43% of deals). Average disclosed round size is $19.2M (across 4 rounds with reported amounts).
Portfolio
7
Fund Size
$600M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Unknown | — | Oct 2022 | |
| Series A | $15M | Jul 2021 | |
| Unknown | — | Jan 2021 | |
| Series A | $12M | Oct 2020 | |
| Series A | $16M | Oct 2019 | |
| Series C | $34M | — | |
| Series C | — | — |
Top Co-Investors
Providence Ventures2 shared
Cigna Ventures1 shared
7wireVentures1 shared
Longitude Capital1 shared
Kaiser Permanente Ventures1 shared
F-Prime Capital1 shared
Eight Roads Ventures1 shared
The Council1 shared
7wire Ventures1 shared
Chicago Ventures1 shared
Hyde Park Angels1 shared
Last updated: 13 March 2026